SXTC icon

China SXT Pharmaceuticals
SXTC

10 hedge funds and large institutions have $491K invested in China SXT Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.2% more ownership

Funds ownership: 0.07% → 0.27% (+0.2%)

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$141K
2
+$85.3K
3
+$77.5K
4
Renaissance Technologies
Renaissance Technologies
New York
+$69.9K
5
HF
HRT Financial
New York
+$42K

Top Sellers

1
-$98.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Invesco
1
Invesco
Georgia
$141K
Geode Capital Management
2
Geode Capital Management
Massachusetts
$85.3K
Citadel Advisors
3
Citadel Advisors
Florida
$77.5K
Renaissance Technologies
4
Renaissance Technologies
New York
$69.9K
VF
5
Virtu Financial
New York
$46K
HF
6
HRT Financial
New York
$42K
TSS
7
Two Sigma Securities
New York
$24.3K
TRCT
8
Tower Research Capital (TRC)
New York
$4.52K
UBS Group
9
UBS Group
Switzerland
$157
SOW
10
State of Wyoming
Wyoming
$142